These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15264983)

  • 21. Comprehensive evaluation of the efficacy and safety of LPV/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19.
    Wu L; Zheng Y; Liu J; Luo R; Wu D; Xu P; Wu D; Li X
    Aging (Albany NY); 2021 Apr; 13(8):10833-10852. PubMed ID: 33879634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lopinavir/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review.
    Vargas M; Servillo G; Einav S
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8592-8605. PubMed ID: 32894567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent developments in the virology and antiviral research of severe acute respiratory syndrome coronavirus.
    Yeung KS; Meanwell NA
    Infect Disord Drug Targets; 2007 Mar; 7(1):29-41. PubMed ID: 17346209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID-19: A retrospective study in two designated hospitals in Anhui, China.
    Zuo Y; Liu Y; Zhong Q; Zhang K; Xu Y; Wang Z
    J Med Virol; 2020 Nov; 92(11):2666-2674. PubMed ID: 32492211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children.
    Leung CW; Chiu WK
    Paediatr Respir Rev; 2004 Dec; 5(4):275-88. PubMed ID: 15531251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2.
    Atzrodt CL; Maknojia I; McCarthy RDP; Oldfield TM; Po J; Ta KTL; Stepp HE; Clements TP
    FEBS J; 2020 Sep; 287(17):3633-3650. PubMed ID: 32446285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe acute respiratory syndrome: scientific and anecdotal evidence for drug treatment.
    Tsang K; Seto WH
    Curr Opin Investig Drugs; 2004 Feb; 5(2):179-85. PubMed ID: 15043392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use.
    Bhatnagar T; Murhekar MV; Soneja M; Gupta N; Giri S; Wig N; Gangakhedkar R
    Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):184-189. PubMed ID: 32362644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of antiviral therapy for severe acute respiratory syndrome.
    Cinatl J; Michaelis M; Hoever G; Preiser W; Doerr HW
    Antiviral Res; 2005 Jun; 66(2-3):81-97. PubMed ID: 15878786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe acute respiratory syndrome (SARS): epidemiology and clinical features.
    Hui DS; Chan MC; Wu AK; Ng PC
    Postgrad Med J; 2004 Jul; 80(945):373-81. PubMed ID: 15254300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Severe acute respiratory syndrome (SARS)].
    Hoheisel G; Luk WK; Winkler J; Gillissen A; Wirtz H; Liebert UG; Hui DS
    Med Klin (Munich); 2006 Dec; 101(12):957-63. PubMed ID: 17171319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe acute respiratory syndrome in children: experience in a regional hospital in Hong Kong.
    Chiu WK; Cheung PC; Ng KL; Ip PL; Sugunan VK; Luk DC; Ma LC; Chan BH; Lo KL; Lai WM
    Pediatr Crit Care Med; 2003 Jul; 4(3):279-83. PubMed ID: 12831407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular advances in severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
    Chow KY; Hon CC; Hui RK; Wong RT; Yip CW; Zeng F; Leung FC
    Genomics Proteomics Bioinformatics; 2003 Nov; 1(4):247-62. PubMed ID: 15629054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.
    Booth CM; Matukas LM; Tomlinson GA; Rachlis AR; Rose DB; Dwosh HA; Walmsley SL; Mazzulli T; Avendano M; Derkach P; Ephtimios IE; Kitai I; Mederski BD; Shadowitz SB; Gold WL; Hawryluck LA; Rea E; Chenkin JS; Cescon DW; Poutanen SM; Detsky AS
    JAMA; 2003 Jun; 289(21):2801-9. PubMed ID: 12734147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New and emerging infectious diseases.
    Spicuzza L; Spicuzza A; La Rosa M; Polosa R; Di Maria G
    Allergy Asthma Proc; 2007; 28(1):28-34. PubMed ID: 17390754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe acute respiratory syndrome.
    Christian MD; Poutanen SM; Loutfy MR; Muller MP; Low DE
    Clin Infect Dis; 2004 May; 38(10):1420-7. PubMed ID: 15156481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cluster of cases of severe acute respiratory syndrome in Hong Kong.
    Tsang KW; Ho PL; Ooi GC; Yee WK; Wang T; Chan-Yeung M; Lam WK; Seto WH; Yam LY; Cheung TM; Wong PC; Lam B; Ip MS; Chan J; Yuen KY; Lai KN
    N Engl J Med; 2003 May; 348(20):1977-85. PubMed ID: 12671062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The management of coronavirus infections with particular reference to SARS.
    Wong SS; Yuen KY
    J Antimicrob Chemother; 2008 Sep; 62(3):437-41. PubMed ID: 18565970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.